Scinai Reports Revenue Growth as CDMO Business Expands
An October agreement advances a U.S. customer program to approximately $5.1 million in committed base.
Related stories
Moderna Raises 2026 Revenue Growth Outlook to 15%–25%
Moderna now expects 2026 revenue growth of 15% to 25%, up from previous guidance of up to 10%, citing stronger international demand for its Covid-19 vaccines. Third-quarter revenue
M impact | EARNINGS | Nov 06, 2026, 02:55 PM UTC
Microchip Shares Hit Over 7 Month Low After Earnings
H impact | EARNINGS | Nov 06, 2026, 02:37 PM UTC
TradeGo FinTech H1 Profit Falls 36%
M impact | EARNINGS | Nov 06, 2026, 02:37 PM UTC
Algoma Central Third-Quarter Profit Jumps on Strong Bulk Demand
Algoma Central reported higher third-quarter profit, citing strong agricultural and construction shipping volumes, expanded fleet capacity and a gain from selling two vessels. The
M impact | EARNINGS | Nov 06, 2026, 02:35 PM UTC
Kura Sushi Shares Sink After Swinging to 4Q Loss, Issuing Underwhelming Outlook
By Connor HartShares of Kura Sushi fell after the company swung to a loss in its latest quarter and reported lower-than-expected sales.The company also issued an underwhelming sale
L impact | EARNINGS | Nov 06, 2026, 02:29 PM UTC
The 3-Quarter Warning I’ve Been Giving You
Why tech stocks are now falling on good earnings — and what it means for your portfolio
H impact | EARNINGS | Nov 06, 2026, 02:15 PM UTC